Analysis of molecular mechanisms of response and resistance to vemurafenib (vem) in BRAFV600E melanoma.
Jeffrey Alan Sosman
Consultant or Advisory Role - Roche
Research Funding - Roche
Anna C. Pavlick
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Lynn Mara Schuchter
Research Funding - Roche
Karl D Lewis
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Grant A. McArthur
Consultant or Advisory Role - Plexxikon; Roche/Genentech
Charles Lance Cowey
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Eisai; Genentech; GlaxoSmithKline; Novartis
Stergios J Moschos
No relevant relationships to disclose
Keith T. Flaherty
Consultant or Advisory Role - Roche/Genentech
Kevin B. Kim
Consultant or Advisory Role - Roche/Genentech
Honoraria - Genentech
Research Funding - Plexxikon; Roche
Jeffrey Weber
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech
Peter Hersey
No relevant relationships to disclose
Georgina V. Long
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Donald P. Lawrence
No relevant relationships to disclose
Mark Kockx
No relevant relationships to disclose
Olivia Spleiss
Employment or Leadership Position - Roche
Astrid Koehler
Employment or Leadership Position - Roche Diagnostics GmbH
Stock Ownership - Roche
Gideon Bollag
Employment or Leadership Position - Plexxikon
Andrew K. Joe
Employment or Leadership Position - Roche
Stock Ownership - Roche
Kerstin Trunzer
Employment or Leadership Position - Roche
Stock Ownership - Roche
Antoni Ribas
Consultant or Advisory Role - Roche/Genentech